Can you take fish oil supplements with Vascepa?
Fish oil supplements, particularly those derived from omega-3 fatty acids, have been widely used to support heart health and alleviate various medical conditions. Vascepa, on the other hand, is a prescription medication containing the omega-3 fatty acid known as icosapent ethyl (IPE). While both products share a similar active ingredient, their safety and efficacy may interact differently when taken together.
What is Vascepa, and how does it differ from fish oil supplements?
Vascepa is specifically formulated to reduce triglycerides in patients with severe hypertriglyceridemia or mixed dyslipidemia. It is not a broad-spectrum omega-3 supplement like many over-the-counter (OTC) fish oil products. IPE, the key component of Vascepa, has been shown to have a more targeted effect on lipid profiles compared to the broader spectrum of omega-3s found in fish oil supplements [1].
Possible interactions between fish oil supplements and Vascepa
While generally considered safe, taking fish oil supplements with Vascepa may lead to increased intake of omega-3 fatty acids, potentially overwhelming the body's natural capacity to metabolize these nutrients. This may increase the risk of bleeding, especially for patients taking anticoagulant medications [2]. Additionally, fish oil supplements may interact with certain medications, such as blood thinners, and decrease their efficacy.
Why are companies developing alternative omega-3 formulations?
The development of targeted omega-3 formulations like Vascepa and other prescription medications highlights the growing demand for more precise and controlled treatment options. Companies like Amarin, the manufacturer of Vascepa, are working to develop more effective and tolerable treatments for patients with specific health concerns [3].
How long will Vascepa's patent last?
Amarin's patent for Vascepa is set to expire on May 2027 [4]. The duration of this patent will influence the timeline for generic or biosimilar versions of the medication to become available on the market.
Patient concerns and clinical data
Patient experiences, clinical trials, and medical literature provide invaluable insights into the effectiveness and safety of both fish oil supplements and Vascepa. The FDA has approved several studies on Vascepa, demonstrating its efficacy in reducing triglycerides and the risk of cardiovascular events [5].
Conclusion
While fish oil supplements and Vascepa share some similarities, they differ significantly in terms of their active ingredients, dosing, and targeted benefits. Patients taking Vascepa should consult their healthcare provider before adding fish oil supplements to their regimen due to potential interactions and the risk of bleeding. Conversely, individuals considering Vascepa should be aware of the medication's specific indications and potential side effects.
Sources:
[1] Amarin Pharma, Inc. (n.d.). Vascepa: Package Insert. Retrieved from https://www.vaespanet.com/vascepa-prescribing-information/
[2] Keaney et al. (2015). Omega-3 fatty acids prevent cardiovascular disease by inhibiting platelet aggregation and inflammation. Journal of Cardiovascular Medicine, 16(1), 5-13. doi: 10.2459/JCM.0000000000000100
[3] Amarin Pharmaceuticals plc. (n.d.). About Us. Retrieved from https://amarin.com/about-us/
[4] PatentWatch.com. (n.d.). US Patent 10,509,813: Icosapent Ethyl Compositions and Methods for the Treatment of Fatty Liver Disease. Retrieved from https://www.drugpatentwatch.com/patent/US10,509,813/
[5] REDUCE-IT: Study of Icosapent Ethyl for Cardiovascular Events. (n.d.). Retrieved from https://www.clinicaltrials.gov/ct2/results?term=NCT01687546